Recombinant proteins are an indispensable tool in drug discovery. The need for multiple forms of recombinant proteins, e.g. wild/mutant/fusion, from different species is increasing and we seek to fulfill the demand providing excellent service and support. (more…)
Screening by MS becomes more and more popular to cover expanding demand in novel research areas in scientific world. Screening by MS includes several approaches with different areas of application which are essential for drug-discovery research. (more…)
The main purpose of the Screening Group is to provide hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory hit finding projects with the industry or academic partners… (more…)
Bioanalytical Laboratory at Bienta offers a broad variety of in vitro ADMET tests as well as pharmacokinetics studies in small animals… (more…)
In order to continue expanding our services in preclinical toxicology and animal efficacy models, in 2016 Bienta launched the new Animal Research Facility for in vivo studies in rodents.
We claim that for animal studies Bienta is strictly following internationally accepted guidelines for ethical animal care (Bienta/Enamine Animal Work Statement). All studies are approved by the Bienta’s Institutional Animal Care and Use Committee (IACUC). Protocol extracts are avaible upon sponsor’s requests.
- Mice strains: Balb/cAnN, C57BL/6N, C57BL/6J, CD1(ICR), NMRI(Han), CDl-Foxnlnu; CB17.Cg-PrkdcscidLystbj-J
- Rats: WI (Wistar), CD (SD)
- Other animals (hamsters, guinea pigs, gerbils) available on request
Our Molecular Modeling group provides cheminformatics, molecular modeling, virtual screening and computational biology services aiming to accelerate hit identification, lead generation and lead optimization stages of the drug discovery process… (more…)